in Newswire December 11, 2018

Class Action Alleges Mylan, Rite Aid Continued to Sell Contaminated High Blood Pressure Drug Despite Sweeping Recalls

by Erin Shaak

Last Updated on December 11, 2018

Cacaccio v. Mylan Pharmaceuticals, Inc. et al.

Filed: December 5, 2018 § 2:18-cv-06916

Mylan and Rite Aid are facing a class action that claims the companies respectively manufactured and sold generic valsartan medications despite possessing knowledge that the drugs were contaminated with probable carcinogen N-nitrosodiethylamine (NDEA).



New York

Last Updated on December 11, 2018 — 4:12 PM

Erin Shaak

Erin works primarily on’s newswire, reporting on cases as they happen.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.